News
Sitaxsentan Proves Effective in Pulmonary Arterial Hypertension : The phase III trial found that the 100-mg dose improved WHO functional class vs. placebo.
- Author:
- Bruce Goldman
Publish date: August 15, 2005
News
Sitaxsentan Better Tolerated Than Bosentan as Oral PAH Therapy
- Author:
- Bruce Goldman
Publish date: August 15, 2005
News
Novel Drug Found Safe, Effective in Pulmonary Arterial Hypertension
- Author:
- Bruce Goldman
Publish date: August 1, 2005